RecruitingNot Applicable

Biomarkers in Prediction of AMI

Estonia, Switzerland250 participantsStarted 2024-10-14

Plain-language summary

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years or older * Initial decision in favour of further diagnostics of mesenteric ischaemia Exclusion Criteria: * Age \<18 years * Consent declined by patient or next of kin (delayed consent) * Chronic mesenteric ischaemia without an acute event * Immediate decision for withdrawal of further diagnostics and active treatment * Referral from another hospital with already established diagnosis of AMI * AMI diagnosed at surgery without previously having been considered

What they're measuring

Rate of correctly predicted cases of acute mesenteric ischaemia

Timeframe: 10 months

Trial details

NCT IDNCT06212921

SponsorUniversity of Tartu

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09

Contact for this trial

Annika Reintam Blaser, PhD

+3725142281 annika.reintam.blaser@ut.ee

View on ClinicalTrials.gov More Acute Mesenteric Ischemia trials